Skip to main content
Premium Trial:

Request an Annual Quote

ZyGem Inks Marketing, R&D Pact with Morpho for Sample Prep, Forensics Products

Premium

ZyGem said this week that it has inked an agreement with law enforcement products firm Morpho, which will market ZyGem's sample-preparation and forensics analysis products to police forces worldwide.

The agreement with Morpho, a subsidiary of international aerospace, defense, and security firm Safran Group, includes a strategic research and development collaboration.

Financial and other terms of the agreement were not disclosed.

ZyGem, based in Charlottesville, Va., develops and markets proprietary technologies to extract DNA and RNA from diverse samples using thermophilic enzymes. The company's PrepGem, ForensicGem, LivestockGem, and RNAGem families of nucleic acid extraction kits are intended for researchers performing a wide variety of life sciences and biomedical studies, including human genotyping, animal testing, and basic research.

ZyGem said that the collaboration with Morpho builds on a separate partnership it has with Lockheed Martin to develop an integrated sample-to-answer DNA testing system for the forensics market (PCR Insider, 5/5/2011).

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.